John LaMattina on the presumably low morale of GSK’s oncology researchers: http://www.forbes.com/sites/johnlamattina/2015/05/12/gsks-curious-oncology-research-position-a-recipe-for-failure It would seem to be hard to retain good scientists in such an environment.